OSI-211
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OSI-211, covering 2011-10-20 to 2011-10-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer [Phase 2]